UBC's Blog

UBC is committed to sharing ideas & insights with the pharmaceutical & biotech industry to address the full product lifecycle & support the development & commercialization of safe & effective products.

 

HealthBridge Pharma & Biotech - April 19, 2012
Expectations, preparation, anticipation, concern.  These were some of the words going through our minds during the time leading up to the Express Scripts-Medco merger.  And, as we began to consider the best ways to combine...
HealthBridge Pharma & Biotech - April 17, 2012
With the Medco merger, Express Scripts now has prescription data for nearly 100 million Americans.  We've been involved in nearly every specialty product launch since 2003, and we've touched nearly every Risk Evaluation &...
HealthBridge Pharma & Biotech - April 13, 2012
The World Orphan Drug Congress being held this week presents a unique opportunity for manufacturers, advocacy groups,  and patient access providers to meet and discuss how we can all work together to take really good care of...
HealthBridge Pharma & Biotech - April 12, 2012
For those of us connected with manufacturing or managing orphan drugs, it's easy to obsess over the numbers:  there are 7,000 designated rare diseases, but fewer than 400 approved orphan drug therapies; more than 30 million...
HealthBridge Pharma & Biotech - April 09, 2012
As Express Scripts and Medco move forward as one company, our commitment to continuity of care, services, and relationships is stronger than ever.  That is why during this time of transition, you and your products will continue...

Pages